Impact of Corona-Phobia on Attitudes and Acceptance Towards COVID-19 Vaccine Among Cancer Patients: a Single-Center Study

Erdem, Dilek; Karaman, İrem

doi:10.2217/fon-2021-1015

Cited by 16 publications

(14 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although a majority of cancer patients such as those in our study are vaccinated, which is consistent with prior reports [ 29 , 30 , 32 , 41 , 42 , 43 ], cancer patients have been an under-represented group in vaccine clinical trials, especially ethnic minorities. Therefore, it may be justified for these patients to have safety concerns and skepticisms.…”

Section: Discussionsupporting

confidence: 91%

“…This concern is further amplified if a patient with COVID-19 is not only unvaccinated but also has comorbidities such as cancer, predisposing them to higher risk of morbidity and mortality. COVID-19 vaccine hesitancy has been studied previously in cancer patients worldwide [ 25 , 26 , 27 , 28 , 29 , 30 , 32 , 39 , 40 , 41 , 42 , 43 , 44 ] and in the United States [ 31 , 33 , 35 , 36 , 45 ], including multiple studies of ethnic minorities in the US [ 21 , 22 , 23 , 24 , 46 , 47 , 48 , 49 , 50 , 51 ], but no known research exists specifically examining ethnic minority cancer patients and their views on the COVID-19 vaccine. This study helps address this gap in the knowledge by uniquely examining two different time-points of vaccination status 6-months post-initial survey, employing a vaccine knowledge score composite and exploring a brief educational intervention to raise patients’ awareness, to gain valuable insight into this distinctly disadvantaged population in the US.…”

Section: Discussionmentioning

confidence: 99%

“…Previous studies surveying cancer patients were conducted mainly during December 2020–February 2021 when the vaccines were not widely available, in predominantly non-Hispanic White patient populations or in countries other than the United States (US) [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. In these studies, overall, the main factors of increased hesitancy included similar reasons such as safety, side effects, process of development, lower education level, history of prior COVID-19, conservative political leaning, mistrust in health care systems, belief COVID is not harmful, and younger age [ 25 , 26 , 27 , 28 , 29 , 30 , 31 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population

et al. 2022

View full text Add to dashboard Cite

Background: Complicating the COVID-19 pandemic are the healthcare disparities experienced by ethnic minorities, especially those with comorbidities including cancer. The introduction of COVID-19 vaccines has been instrumental in blunting the morbidity and mortality from the pandemic; however, vaccine hesitancy, particularly among ethnic minorities, has been a major concern. Thus, we sought to evaluate the knowledge and perspectives of COVID-19 and vaccines among our ethnic minority cancer patient population. Methods: Following an IRB approved protocol, questionnaires were completed by patients in a predominantly ethnic minority population at a single institution between 1 February and 30 June 2021. Included were any adult cancer patients with either a solid or hematologic malignancy. Results: Among the 84 patients that were offered the questionnaires, 52 patients responded, with a median age of 63.5 years. Overall, 36% were non-Hispanic Blacks and 30% were Hispanics; 65% were receiving active treatment for their cancer. Seventy-nine percent believed COVID-19 to be dangerous or harmful to them, 61% were concerned about the side effects, yet 65% considered COVID-19 vaccines as safe. Among the seven patients that refused the vaccine, (71%, n = 5) cited side effects and/or (57%, n = 4) believed that the vaccine was not needed. Overall, there was a significantly higher chance of being vaccinated if patients were receiving active cancer treatment, believed COVID-19 was harmful, or that the vaccine was safe, and knew COVID-19 was a virus. Conclusions: This exploratory study demonstrates that most ethnic minority cancer patients are receptive to vaccines, with a majority being vaccinated. However, we also discovered various reasons why this group of patients may not want be vaccinated, including concerns about side effects and perception that COVID-19 is not harmful. These findings can help us further understand the complex nature of vaccine hesitancy in ethnic minority cancer patients, and aid in developing future vaccine awareness strategies as the COVID-19 pandemic continues to evolve.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The rate increased to 91% of participants who received their attending physician’s recommendation for vaccination [ 99 ]. Results from several other studies further support the notion that recommendations coming from a patient’s oncologist would be well received by cancer patients [ 97 , 100 ]. Therefore, it is imperative that all oncological providers are well informed of the most accurate and up-to-date recommendations regarding vaccination and to start discussions with their patients to address their concerns.…”

Section: Hesitancy/acceptance Of the Covid-19 Vaccination Among Cance...mentioning

confidence: 52%

Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges

Almasri

Bshesh

Khan

et al. 2022

Cancers

View full text Add to dashboard Cite

Few guidelines exist for COVID-19 vaccination amongst cancer patients, fostering uncertainty regarding the immunogenicity, safety, and effects of cancer therapies on vaccination, which this review aims to address. A literature review was conducted to include the latest articles covering the immunogenicity and safety of COVID-19 vaccination in patients with solid and hematologic cancers receiving various treatments. Lower seropositivity following vaccination was associated with malignancy (compared to the general population), and hematologic malignancy (compared to solid cancers). Patients receiving active cancer therapy (unspecified), chemotherapy, radiotherapy, and immunosuppressants generally demonstrated lower seropositivity compared to healthy controls; though checkpoint inhibition, endocrine therapy, and cyclin dependent kinase inhibition did not appear to affect seropositivity. Vaccination appeared safe and well-tolerated in patients with current or past cancer and those undergoing treatment. Adverse events were comparable to the general population, but inflammatory lymphadenopathy following vaccination was commonly reported and may be mistaken for malignant etiology. Additionally, radiation recall phenomenon was sporadically reported in patients who had received radiotherapy. Overall, while seropositivity rates were decreased, cancer patients showed capacity to generate safe and effective immune responses to COVID-19 vaccination, thus vaccination should be encouraged and hesitancy should be addressed in this population.

show abstract

“…The psychological, psychosomatic, and economic sub-dimensions of the C19P-S and the total C19P-S scores of women were significantly higher than those of men. Single patients' C19P-S psychosomatic subgroup scores were sig-nificantly higher than those of married patients (17). In a study investigating coronaphobia risk factors in adult patients, female sex, being married, having a chronic illness, staying at home, and accompanying sleep disorders were associated with high coronaphobia scores (14).…”

Section: Discussionmentioning

confidence: 92%

Level of Coronaphobia in Older Adult Patient

Ertem¹

2022

tjgeri

View full text Add to dashboard Cite

Impact of Corona-Phobia on Attitudes and Acceptance Towards COVID-19 Vaccine Among Cancer Patients: a Single-Center Study

Cited by 16 publications

References 38 publications

Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population

Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population

Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges

Level of Coronaphobia in Older Adult Patient

Contact Info

Product

Resources

About